2,410 results match your criteria International journal of technology assessment in health care[Journal]


Quality Assessment of Reporting of Economic Evaluation in Cardiac Sugery: Has it Improved?

Int J Technol Assess Health Care 2019 Feb 12:1-5. Epub 2019 Feb 12.

Service de Chirurgie Cardiaque,Hôpital Cardiologique Louis Pradel,Université Claude Bernard.

Objectives: Cardiac surgery has seen substantial scientific progress over recent decades. Health economic evaluations have become important tools for decision makers to prioritize scarce health resources. The present study aimed to identify and critically appraise the reporting quality of health economic evaluations conducted in the field of cardiac surgery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003768DOI Listing
February 2019

Nudging in Neonatology: Practical Wisdom and Accountability for Reasonableness.

Authors:
Michal Stanak

Int J Technol Assess Health Care 2019 Feb 12:1-5. Epub 2019 Feb 12.

Ludwig Boltzmann Institute for Health Technology Assessment and Department of Philosophy,University of Vienna.

Objectives: The way choice is presented has an impact on decision-making. This is the case also in the context of neonatal intensive care units (NICUs), particularly in the challenging cases that concern the limit of viability. The objective of this article is to examine the role of nudging in the shared decision-making in neonatology and elaborate on the respective moral challenges. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003732DOI Listing
February 2019

Early assessment of innovation in a healthcare setting.

Int J Technol Assess Health Care 2019 Feb 12:1-10. Epub 2019 Feb 12.

Oslo University Hospital,Centre for Connected Care.

Objectives: Early assessment can assist in allocating resources for innovation effectively and produce the most beneficial technology for an institution. The aim of the present study was to identify methods and discuss the analytical approaches applied for the early assessment of innovation in a healthcare setting.

Methods: Knowledge synthesis based on a structured search (using the MEDLINE, Embase, and Cochrane databases) and thematic analysis was conducted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003719DOI Listing
February 2019

How Procurement Judges The Value of Medical Technologies: A Review of Healthcare Tenders.

Int J Technol Assess Health Care 2019 Feb 8:1-6. Epub 2019 Feb 8.

Institute of Health Policy,Management and Evaluation, University of Toronto.

Objectives: Procurement's important role in healthcare decision making has encouraged criticism and calls for greater collaboration with health technology assessment (HTA), and necessitates detailed analysis of how procurement approaches the decision task.

Methods: We reviewed tender documents that solicit medical technologies for patient care in Canada, focusing on request for proposal (RFP) tenders that assess quality and cost, supplemented by a census of all tender types. We extracted data to assess (i) use of group purchasing organizations (GPOs) as buyers, (ii) evaluation criteria and rubrics, and (iii) contract terms, as indicators of supplier type and market conditions. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003756DOI Listing
February 2019
1 Read

Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.

Int J Technol Assess Health Care 2019 Feb 7:1-8. Epub 2019 Feb 7.

ACCU Confederation.

Objectives: Patient involvement in drug evaluation decision making is increasing. The aim of the current study was to develop a multi-criteria decision analysis (MCDA) framework that would enable the inclusion of the patient perspective in the selection of appropriate criteria for MCDAs being used in the value assessments of oncologic drugs.

Methods: A literature review was conducted to identify and define criteria used in drug assessments from patient perspectives. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003641DOI Listing
February 2019
1 Read

Rheumatoid arthritis treated with 6-months of first-line biologic or biosimilar therapy: an updated systematic review and network meta-analysis.

Int J Technol Assess Health Care 2019 Feb 6:1-9. Epub 2019 Feb 6.

Department of Economic and Public Health Evaluation,French National Authority for Health (HAS), Saint-Denis La Plaine,France.

Objectives: The aim of this study was to estimate the effectiveness of first-line biologic disease modifying drugs(boDMARDs), and their approved biosimilars (bsDMARDs), compared with conventional (csDMARD) treatment, in terms of ACR (American College of Rheumatology) and EULAR (European League against Rheumatism) responses.

Methods: Systematic literature search, on eight databases to January 2017, sought ACR and EULAR data from randomized controlled trials (RCTs) of boDMARDs / bsDMARDs (in combination with csDMARDs, or monotherapy). Two adult populations: methotrexate (MTX)-naïve patients with severe active RA; and csDMARD-experienced patients with moderate-to-severe active RA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003628DOI Listing
February 2019
1 Read

What is the impact of physicians in prehospital treatment for patients in need of acute critical care? - An overview of reviews.

Int J Technol Assess Health Care 2019 Feb 6:1-9. Epub 2019 Feb 6.

DEFACTUM,Department of Public Health and Health Services Research.

Objectives: The aim of this overview was to systematically identify and synthesize existing evidence from systematic reviews on the impact of prehospital physician involvement.

Methods: The Medline, Embase, and Cochrane library were searched from 1 January 2000 to 17 November 2017. We included systematic reviews comparing physician-based with non-physician-based prehospital treatment in patients with one of five critical conditions requiring a rapid response. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003616DOI Listing
February 2019

Selecting digital health technologies for validation and piloting by healthcare providers: a decision-making perspective from ontario.

Int J Technol Assess Health Care 2019 Feb 4:1-4. Epub 2019 Feb 4.

Thunder Bay Regional Health Research Institute.

Digital health technologies (DHTs) such as health apps are rapidly emerging as a major disruptor of health care. Yet there is no well-established process of decision making for selecting DHTs that are worthy of investing resources in their validation to determine whether they are ready (safe, effective, and not too costly) for health related use. We report here on an Ontario-based initiative to support such decision making. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003720DOI Listing
February 2019

RESPONSE TO ON THE COSTS OF HOME-BASED TELEMEDICINE PROGRAMS: A COMMENT ON MICHAUD ET AL.

Authors:
Tzeyu L Michaud

Int J Technol Assess Health Care 2018 Jan;34(6):594

Center for Reducing Health Disparities, College of Public Health,Department of Health Promotion, College of Public Health, University of Nebraska Medical Center Omaha,

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003677DOI Listing
January 2018
1 Read

ON THE COSTS OF HOME-BASED TELEMEDICINE PROGRAMS: A COMMENT ON MICHAUD ET AL.

Authors:
Kristian Kidholm

Int J Technol Assess Health Care 2018 Jan;34(6):593

Center for Innovative Medical Technology, Odense University Hospital,Denmark.

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003665DOI Listing
January 2018
1 Read

SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS - ERRATUM.

Int J Technol Assess Health Care 2018 Jan;34(6):595

Institute for Research in Operative Medicine, Witten/Herdecke University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S026646231800363XDOI Listing
January 2018

COMBINING INSTITUTIONAL AND ADMINISTRATIVE DATA TO ASSESS HOSPITAL COSTS FOR PATIENTS RECEIVING VENTRICULAR ASSIST DEVICES.

Int J Technol Assess Health Care 2018 Jan;34(6):555-566

St Vincent's Hospital,Faculty of Health University of Technology

Objectives: The aim of this study was to describe patient level costing methods and develop a database of healthcare resource use and cost in patients with AHF receiving ventricular assist device (VAD) therapy.

Methods: Patient level micro-costing was used to identify documented activity in the years preceding and following VAD implantation, and preceding heart transplant for a cohort of seventy-seven consecutive patients listed for heart transplantation (2009-12). Clinician interviews verified activity, established time resource required for each activity, and added additional undocumented activities. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003586DOI Listing
January 2018
7 Reads

COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND.

Int J Technol Assess Health Care 2018 Dec 18:1-9. Epub 2018 Dec 18.

Department of Pharmacy,Faculty of Pharmacy,Mahidol University.

Objectives: Although interferon beta-1a (IFNß-1a), 1b (IFNß-1b), and fingolimod have been approved as multiple sclerosis (MS) treatments, they have not yet been included on the National List of Essential Medicines (NLEM) formulary in Thailand. This study aimed to evaluate the cost-utility of MS treatments compared with best supportive care (BSC) based on a societal perspective in Thailand.

Methods: A Markov model with cost and health outcomes over a lifetime horizon with a 1-month cycle length was conducted for relapsing-remitting MS (RRMS) patients. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318003604DOI Listing
December 2018
5 Reads

COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN.

Int J Technol Assess Health Care 2018 Dec 18:1-8. Epub 2018 Dec 18.

Social Determinants of Health Research Center, Mashhad University of Medical Sciences Non-Communicable Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical

Objectives: This study aimed to assess the cost-effectiveness of ivabradine plus standard of care (SoC) in comparison with current SoC alone from the Iranian payer perspective.

Methods: A cohort-based Markov model was developed to assess the incremental cost-effectiveness ratio (ICER) over a 10-year time horizon in a cohort of 1,000 patients. The baseline transition probabilities between New York Heart Association (NYHA), mortality rate, and hospitalization rate were extracted from the literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318003598DOI Listing
December 2018
1 Read

AGING AND HEALTH TECHNOLOGY ASSESSMENT: AN IDEA WHOSE TIME HAS COME.

Int J Technol Assess Health Care 2018 Jan;34(5):442-446

University of

Objectives: With the increase in technologies to support an aging population, health technology assessment (HTA) of aging-related technologies warrants special consideration. At Health Technology Assessment international (HTAi) 2016 and HTAi 2017, an international panel explored interests in HTA focused on aging.

Methods: Panelists from five countries shared the state of aging and HTA in their countries. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000600DOI Listing
January 2018
11 Reads

WHICH DATABASES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS?

Int J Technol Assess Health Care 2018 Jan 16;34(6):547-554. Epub 2018 Nov 16.

York Health Economics Consortium (YHEC).

Objectives: This study investigated which databases and which combinations of databases should be used to identify economic evaluations (EEs) to inform systematic reviews. It also investigated the characteristics of studies not identified in database searches and evaluated the success of MEDLINE search strategies used within typical reviews in retrieving EEs in MEDLINE.

Methods: A quasi-gold standard (QGS) set of EEs was collected from reviews of EEs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000636DOI Listing
January 2018

REAL-WORLD CLINICAL EVALUATION AND COSTS OF TELEMEDICINE FOR CHRONIC WOUND MANAGEMENT.

Int J Technol Assess Health Care 2018 Jan 29;34(6):567-575. Epub 2018 Oct 29.

Caen University Hospital Center.

Background: Chronic wounds are frequent, affect quality of life, and increase care costs. Telemedicine provides potential for effective wound care management, especially for the monitoring of complex wounds at home.

Objectives: The objective of the present study was to determine the clinical effects and costs of telemedicine for the follow-up of complex chronic wounds from the perspective of the public health insurance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000685DOI Listing
January 2018
16 Reads

HOW BAR CODED MEDICATION ADMINISTRATION TECHNOLOGY AFFECTS THE NURSE-PATIENT RELATIONSHIPS: AN ETHNOGRAPHIC STUDY.

Int J Technol Assess Health Care 2018 Jan 26;34(5):507-513. Epub 2018 Oct 26.

Department of Care Ethics,University of Humanistic Studies.

Objectives: This study aims to assess how care is mediated through technology by analyzing the interaction between nurses, patients, and a Bar Coded Medication Administration (BCMA) system. The objective is to explore how patients experience care through medication technology, with the main focus of our observations and interviews on nurses rather than patients.

Methods: A qualitative ethnographic study was conducted in an orthopedic ward of a Dutch general hospital. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000582DOI Listing
January 2018

MULTI-CRITERIA DECISION ANALYSIS AS A DECISION-SUPPORT TOOL FOR DRUG EVALUATION: A PILOT STUDY IN A PHARMACY AND THERAPEUTICS COMMITTEE SETTING.

Int J Technol Assess Health Care 2018 Jan 23;34(5):519-526. Epub 2018 Oct 23.

Department of Pharmacy,Hospital Universitario Virgen Macarena.

Objectives: The aim of this study was to develop and to assess a specific Multi-Criteria Decision Analysis (MCDA) framework to evaluate new drugs in an hospital pharmacy and therapeutics committee (P&TC) setting.

Methods: A pilot criteria framework was developed based on the EVIDEM (Evidence and Value: Impact on DEcisionMaking) framework, together with other relevant criteria, and assessed by a group of P&TC's members. The weighting of included criteria was done using a 5-point weighting technique. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000569DOI Listing
January 2018
7 Reads

SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTH TECHNOLOGY ASSESSMENT: A REVIEW OF CHARACTERISTICS AND APPLIED METHODS.

Int J Technol Assess Health Care 2018 Jan 22;34(6):537-546. Epub 2018 Oct 22.

Institute for Research in Operative Medicine.

Objectives: When making decisions in health care, it is essential to consider economic evidence about an intervention. The objective of this study was to analyze the methods applied for systematic reviews of health economic evaluations (SR-HEs) in HTA and to identify common challenges.

Methods: We manually searched the Web pages of HTA organizations and included HTA-reports published since 2015. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000624DOI Listing
January 2018
10 Reads

IS THE EUNETHTA HTA CORE MODEL® FIT FOR PURPOSE? EVALUATION FROM AN INDUSTRY PERSPECTIVE.

Int J Technol Assess Health Care 2018 Jan 18;34(5):458-463. Epub 2018 Oct 18.

Faculty of Health Sciences,University of Southern Denmark.

Objectives: The HTA Core Model® was developed to improve the transferability of health technology assessment (HTA) between settings. The model has been used by HTA agencies but is also of interest to manufacturers, for improving internal evidence generation and communicating with other HTA stakeholders. To establish if the model is fit for purpose from an industry perspective, the pharmaceutical company Roche, collaborating with the European Network for HTA (EUnetHTA), conducted an assessment of the model. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000594DOI Listing
January 2018
1 Read

COST, CONTEXT, AND DECISIONS IN HEALTH ECONOMICS AND HEALTH TECHNOLOGY ASSESSMENT.

Authors:
Anthony J Culyer

Int J Technol Assess Health Care 2018 Jan 17;34(5):434-441. Epub 2018 Oct 17.

University of York - Economics & Related

Objectives: This study is an attempt to demystify and clarify the idea of cost in health economics and health technology assessment (HTA).

Methods: Its method draws on standard concepts in economics. Cost is a more elusive concept than is commonly thought and can be particularly elusive in multidisciplinary territory like HTA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000612DOI Listing
January 2018

SHARING AND COLLECTING HOSPITAL-BASED HEALTH TECHNOLOGY ASSESSMENT REPORTS INTERNATIONALLY: IS AN EXTENSIVE PARTICIPATION OF STAKEHOLDERS REALISTIC?

Int J Technol Assess Health Care 2018 Jan 16;34(5):527-534. Epub 2018 Oct 16.

Italian National Institute for Health National Center for Health Technology Assessment.

Objectives: The emergence of new medical technologies and budget restrictions has led to a substantial increase in the use of hospital-based health technology assessment (HB-HTA). This qualitative study explores whether there is a possibility and interest to realize the collection and dissemination of HB-HTA reports on an international scale by exploring the opinions from HB-HTA experts.

Methods: A survey was designed and sent to an international group of experts knowledgeable in HB-HTA from eighteen different countries. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000570DOI Listing
January 2018
1 Read

COST-EFFECTIVENESS OF INTERVENTIONS BASED ON PHYSICAL ACTIVITY IN THE TREATMENT OF CHRONIC CONDITIONS: A SYSTEMATIC LITERATURE REVIEW.

Int J Technol Assess Health Care 2018 Jan 9;34(5):481-497. Epub 2018 Oct 9.

Hospinnomics - PSE - École d'économie de Paris,Assistance publique Hôpitaux de Paris.

Objectives: The aim of this study is to review evidence on the cost-effectiveness of exercise-based interventions in the treatment of chronic conditions a decade after the publication of Roine et al. in 2009 (Roine E, Roine RP, Räsänen P, et al. Int J Technol Assess Health Care. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000533DOI Listing
January 2018
2 Reads

ETHICS IN HEALTH TECHNOLOGY ASSESSMENT: A SYSTEMATIC REVIEW.

Int J Technol Assess Health Care 2018 Jan 9;34(5):447-457. Epub 2018 Oct 9.

Faculté de médecine et des sciences de la santé,Université de Sherbrooke,Sherbrooke.

Objectives: Integration of ethics into health technology assessment (HTA) remains challenging for HTA practitioners. We conducted a systematic review on social and methodological issues related to ethical analysis in HTA. We examined: (1) reasons for integrating ethics (social needs); (2) obstacles to ethical integration; (3) concepts and processes deployed in ethical evaluation (more specifically value judgments) and critical analyses of formal experimentations of ethical evaluation in HTA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000508DOI Listing
January 2018
9 Reads

PREFERENCES OF PATIENTS WITH MULTIPLE SCLEROSIS FOR ATTRIBUTES OF INJECTABLE MULTIPLE SCLEROSIS TREATMENTS IN THE UNITED KINGDOM AND FRANCE.

Int J Technol Assess Health Care 2018 Jan;34(4):425-433

RTI Health Solutions.

Objectives: Adherence to injectable disease-modifying treatments in patients with multiple sclerosis (MS) impacts outcomes and can be influenced by perceptions of treatment efficacy, side effects, injection frequency, and the duration of injection. This study aimed to quantify preferences for selected attributes of injectable treatments among individuals with MS in the United Kingdom and France.

Methods: Respondents with a self-reported diagnosis of MS completed an online discrete-choice-experiment survey, consisting of a series of treatment-choice questions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190072PMC
January 2018

QUALITY ASSURANCE OF REGISTRIES FOR HEALTH TECHNOLOGY ASSESSMENT.

Int J Technol Assess Health Care 2018 Jan;34(4):360-367

National Institute for Health and Care

Objectives: The aim of this study was to identify guidelines and assessment tools used by health technology agencies for quality assurance of registries and investigate the current use of registry data by HTA organizations worldwide.

Methods: As part of a European Network for Health Technology Assessment Joint Action work package, we undertook a literature search and sent a questionnaire to all partner organizations on the work package and all organizations listed in the International Society for Pharmaco-economics and Outcomes Research directory.

Results: We identified thirteen relevant documents relating to quality assurance of registries. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000478DOI Listing
January 2018
13 Reads

DIFFERENTIATION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES BETWEEN FIVE DISEASE AREAS: RESULTS FROM AN INTERNATIONAL SURVEY OF PATIENTS.

Int J Technol Assess Health Care 2018 Jan 25;34(5):498-506. Epub 2018 Sep 25.

Department of Social Policy,Medical Technology Research Group,LSE Health.

Objectives: Health-related quality of life (HRQoL) data generated by generic, preference-based instruments (i.e., EQ-5D) are highly demanded in health policy decision making, because they allow for direct comparisons of HRQoL outcomes between disease areas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000557DOI Listing
January 2018
2 Reads

EARLY DIALOGUE IN EUROPE: PERSPECTIVES ON VALUE, CHALLENGES, AND CONTINUING EVOLUTION.

Int J Technol Assess Health Care 2018 Jan 24;34(5):514-518. Epub 2018 Sep 24.

Department of Health Services Research,CAPHRI Care and Public Health Research Institute,Maastricht University.

Objectives: This study aims to assess participants' views on previous experiences, the current situation and future perspectives for early dialogue between the pharmaceutical industry, a regulatory agency and health technology assessment bodies (HTABs) in Europe.

Methods: Eleven semi-structured interviews were arranged purposively with experienced people from the pharmaceutical industry, the European Medicines Agency, and an expert in Health Economics. The interview questions focused on the value of early dialogue, the challenges faced during the process of early dialogue, the best time to start an early dialogue, the kind of products most suitable for early dialogue, the current situation, and future perspectives for the early dialogue process. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000545DOI Listing
January 2018
1 Read

QUALITY AND USE OF FREE SMOKING CESSATION APPS FOR SMARTPHONES.

Int J Technol Assess Health Care 2018 Jan 18;34(5):476-480. Epub 2018 Sep 18.

Department of Medical

Objectives: Smartphone Apps are one of the tools available to support patients who wish to quit smoking. Content analysis studies have indicated multiple deficiencies within these Apps including minimal use of evidence-based research and Nicotine Dependence Treatment Provider (NDTP) in App development. The aim of this study was to determine quality and features of smoking cessation Apps available on Android® and iOS® platforms. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000521DOI Listing
January 2018
3 Reads

SUITABILITY OF CURRENT EVALUATION FRAMEWORKS FOR USE IN THE HEALTH TECHNOLOGY ASSESSMENT OF MOBILE MEDICAL APPLICATIONS: A SYSTEMATIC REVIEW.

Int J Technol Assess Health Care 2018 Jan 11;34(5):464-475. Epub 2018 Sep 11.

Adelaide Health Technology (AHTA),School of Public Health, The University of Adelaide.

Objectives: To identify and appraise existing evaluation frameworks for mobile medical applications (MMA) and determine their suitability for use in health technology assessment (HTA) of these technologies.

Methods: Systematic searches were conducted of seven bibliographic databases to identify literature published between 2008 and 2016 on MMA evaluation frameworks. Frameworks were eligible if they were used to evaluate at least one of the HTA domains of effectiveness, safety, and/or cost and cost-effectiveness of an MMA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S026646231800051XDOI Listing
January 2018

EVIDENCE REQUIRED BY HEALTH TECHNOLGY ASSESSMENT AND REIMBURSEMENT BODIES EVALUATING DIAGNOSTIC OR PROGNOSTIC ALGORITHMS THAT INCLUDE OMICS DATA.

Int J Technol Assess Health Care 2018 Jan 23;34(4):368-377. Epub 2018 Aug 23.

Assistance Publique - Hôpitaux de Paris,URC-éco.

Objectives: Multi-analyte assays with algorithmic analyses (MAAAs) use combinations of circulating and clinical markers including omics-based sources for diagnostic and/or prognostic purposes. Assessing MAAAs is challenging under existing health technology assessment (HTA) methods or practices. We undertook a scoping review to explore the HTA methods used for MAAAs to identify the criteria used for clinical research and reimbursement purposes. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S026646231800048XDOI Listing
January 2018
12 Reads

COSTS OF HOME-BASED TELEMEDICINE PROGRAMS: A SYSTEMATIC REVIEW.

Int J Technol Assess Health Care 2018 Jan 30;34(4):410-418. Epub 2018 Jul 30.

Center for Reducing Health Disparities, College of Public Health.

Objectives: The aim of this study was to systematically investigate existing literature on the costs of home-based telemedicine programs, and to further summarize how the costs of these telemedicine programs vary by equipment and services provided.

Methods: We undertook a systematic review of related literature by searching electronic bibliographic databases and identifying studies published from January 1, 2000, to November 30, 2017. The search was restricted to studies published in English, results from adult patients, and evaluation of home telemedicine programs implemented in the United States. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000454DOI Listing
January 2018

EXPOSURE IN VIVO VERSUS PAIN-CONTINGENT PHYSICAL THERAPY IN COMPLEX REGIONAL PAIN SYNDROME TYPE I: A COST-EFFECTIVENESS ANALYSIS.

Int J Technol Assess Health Care 2018 Jan 26;34(4):400-409. Epub 2018 Jul 26.

Department of Clinical Psychological Science,Maastricht University CAPHRI - School for Public Health and Primary Care, Department of Rehabilitation Medicine, Maastricht University.

Objectives: The aim of this study was to evaluate the cost-effectiveness of exposure in vivo (EXP, a cognitive-behavioral treatment targeting pain-related fear) in Complex Regional Pain Syndrome Type I (CRPS-I), as compared to pain-contingent physical therapy (PPT).

Methods: Data from a randomized controlled trial were used to compare the cost-effectiveness of EXP versus PPT from a societal perspective. Intervention costs, other healthcare costs, costs to patient and family, and productivity losses were included. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000429DOI Listing
January 2018
7 Reads
1.560 Impact Factor

ASSESSING THE VALUE OF INNOVATIVE MEDICAL DEVICES AND DIAGNOSTICS: THE IMPORTANCE OF CLEAR AND RELEVANT CLAIMS OF BENEFIT.

Int J Technol Assess Health Care 2018 Jan 20;34(4):419-424. Epub 2018 Jul 20.

Objectives: Large numbers of new medical devices and diagnostics are developed and health services need to identify which ones offer real advantages. The National Institute for Health and Care Excellence (NICE) has introduced a system for assessing technologies that are often notified by companies, based on claims made for their benefits to patients, the National Health Service, and the environment.

Methods: Detailed scrutiny of claims made for the benefits of products and the corresponding evidence, seeking associations between these and the selection of products for full evaluation to produce NICE guidance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000466DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190073PMC
January 2018

IMPACT OF HEALTH TECHNOLOGY ASSESSMENT REPORTS ON HOSPITAL DECISION MAKERS - 10-YEAR INSIGHT FROM A HOSPITAL UNIT IN SHERBROOKE, CANADA: IMPACT OF HEALTH TECHNOLOGY ASSESSMENT ON HOSPITAL DECISIONS.

Int J Technol Assess Health Care 2018 Jan 19;34(4):393-399. Epub 2018 Jul 19.

UETMIS,CIUSSS de l'Estrie - CHUS,Sherbrooke,Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS),Department of Medicine,Faculty of Medicine and Health Sciences,University of Sherbrooke.

Objectives: The overarching goal of this research was to (i) evaluate the impact of reports with recommendations provided by a hospital-based health technology assessment (HB-HTA) unit on the local hospital decision-making processes and implementation activities and (ii) identify the underlying factors of the nonimplementation of recommendations.

Methods: All reports produced by the HB-HTA unit between December 2003 and March 2013 were retrieved, and hospital decision makers who requested these reports were solicited for enrolment. Participants were interviewed using a mixed design survey. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000405DOI Listing
January 2018
1 Read

VALUE AND PERFORMANCE OF ACCOUNTABLE CARE ORGANIZATIONS: A COST-MINIMIZATION ANALYSIS.

Int J Technol Assess Health Care 2018 Jan 11;34(4):388-392. Epub 2018 Jul 11.

Department of Health Policy & Management,Johns Hopkins Bloomberg School of Public

Objectives: Determine the relationship between quality of an accountable care organization (ACO) and its long-term reduction in healthcare costs.

Methods: We conducted a cost minimization analysis. Using Centers for Medicare and Medicaid cost and quality data, we calculated weighted composite quality scores for each ACO and organization-level cost savings. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000399DOI Listing
January 2018
24 Reads

CHALLENGES AND METHODOLOGIES IN USING PROGRESSION FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN ONCOLOGY.

Int J Technol Assess Health Care 2018 Jan;34(3):300-316

ScHARR, University of Sheffield.

Objectives: A primary outcome in oncology trials is overall survival (OS). However, to estimate OS accurately requires a sufficient number of patients to have died, which may take a long time. If an alternative end point is sufficiently highly correlated with OS, it can be used as a surrogate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000338DOI Listing
January 2018
1 Read

DEFINING INNOVATION WITH RESPECT TO NEW MEDICINES: A SYSTEMATIC REVIEW FROM A PAYER PERSPECTIVE.

Int J Technol Assess Health Care 2018 Jan;34(3):224-240

School of Economics and Management, LIUC University.

Objectives: The aim of this study was to investigate how innovation is defined with respect to new medicines.

Methods: MEDLINE, Embase, and EconLit databases were searched for articles published between January 1, 2010 and May 25, 2016 that described a relevant definition of innovation. Identified definitions were analyzed by mapping the concepts described onto a set of ten dimensions of innovation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000259DOI Listing
January 2018
17 Reads

DEVELOPMENT OF THE ONTARIO DECISION FRAMEWORK: A VALUES BASED FRAMEWORK FOR HEALTH TECHNOLOGY ASSESSMENT.

Int J Technol Assess Health Care 2018 Jan;34(3):290-299

Health Quality Ontario, Evidence Development and Standards.

Objectives: In 2007, the Ontario Health Technology Advisory Committee (OHTAC) developed a decision framework to guide decision making around nondrug health technologies. In 2012, OHTAC commissioned a revision of this framework to enhance its usability and deepen its conceptual and theoretical foundations.

Methods: The committee overseeing this work used several methods: (a) a priori consensus on guiding principles, (b) a scoping review of decision attributes and processes used globally in health technology assessment (HTA), (c) presentations by methods experts and members of review committees, and (d) committee deliberations over a period of 3 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000235DOI Listing
January 2018
32 Reads

PATIENT PRIORITIES FOR TREATMENT ATTRIBUTES IN ADJUNCTIVE DRUG THERAPY OF SEVERE HYPERCHOLESTEROLEMIA IN GERMANY: AN ANALYTIC HIERARCHY PROCESS.

Int J Technol Assess Health Care 2018 Jan;34(3):267-275

Hochschule Neubrandenburg.

Objectives: Severe hypercholesterolemia is a major cause of death in coronary heart disease. New adjunctive drug therapies have passed authorization processes and been launched recently. So far it is not known which properties of the new treatment options generate the highest benefit for patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000247DOI Listing
January 2018
25 Reads

OVERCOMING THE BARRIERS TO ACHIEVING UNIVERSAL HEALTH CARE IN THE ASIAN REGION.

Int J Technol Assess Health Care 2018 Jan 10;34(4):352-359. Epub 2018 Jul 10.

Chair,HTAi Asia Policy Forum,Department of Haematology,Royal Adelaide Hospital,South Australia.

Objectives: The Health Technology Assessment International (HTAi) Asia Policy Forum (HAPF) met to discuss the challenges of achieving universal health care (UHC) in Asia.

Methods: Group discussions and presentations at the 2017 HAPF, informed by a background paper, including a literature review and the results of pre-meeting surveys of health technology assessment (HTA) agencies and industry, formed the basis of this article.

Results: Affordability was identified as the greatest barrier to establishing UHC; however, other impediments include the lack of political will to implement UHC, and the cultural issue of deference to expert opinion instead of evidence-based assessments. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000417DOI Listing
January 2018

HEALTH TECHNOLOGY ASSESSMENT UNIT PROCESSES FOR THE VALIDATION OF AN INFORMATION TOOL TO INVOLVE PATIENTS IN THE SAFETY OF THEIR CARE.

Int J Technol Assess Health Care 2018 Jan 10;34(4):378-387. Epub 2018 Jul 10.

CRCHUS,CIUSSS de l'Estrie - CHUS,Sherbrooke.

Introduction: Patients and families play an important role in preventing adverse events. The quality council at our hospital produced a communication tool in considering the main causes of adverse events and requested the health technology assessment (HTA) unit to validate it.

Objectives: Assess the validity of the content of a tablemat sticker as an information tool for hospitalized patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000375DOI Listing
January 2018
14 Reads

PERFORMANCE OF SMARTPHONE-BASED DIGITAL IMAGES FOR CERVICAL CANCER SCREENING IN A LOW-RESOURCE CONTEXT.

Int J Technol Assess Health Care 2018 Jan 20;34(3):337-342. Epub 2018 Jun 20.

Geneva Foundation for Medical Education and Research.

Objectives: Colposcopes are expensive, heavy, and need specialized technical service, which may outreach the capacity of low-resource settings. Our aim was to assess the performance of smartphone-based digital images for the detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+).

Methods: Human papillomavirus (HPV)-positive women recruited through a cervical cancer screening campaign had VIA/VILI assessment (visual inspection after application of acetic acid/lugol's iodine). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000260DOI Listing
January 2018
2 Reads

HISTORICAL DEVELOPMENT OF THE HTAsiaLINK NETWORK AND ITS KEY DETERMINANTS OF SUCCESS.

Int J Technol Assess Health Care 2018 Jan 18;34(3):260-266. Epub 2018 Jun 18.

Health Intervention and Technology Assessment Program (HITAP).

Objectives: The aim of this study was to describe the historical development of the HTAsiaLink network, draw lessons for other similar initiatives globally, and to analyze key determinants of its success and challenges for its future development.

Methods: This study is based on the collective and direct experiences of the founding members of the HTAsiaLink Network. Data were collected from presentations they made at various international forums and additional information was reviewed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000223DOI Listing
January 2018
11 Reads

THE GAP BETWEEN ECONOMIC EVALUATIONS AND CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON DABIGATRAN FOR ATRIAL FIBRILLATION.

Int J Technol Assess Health Care 2018 Jan 18;34(3):327-336. Epub 2018 Jun 18.

Department for Health Evidence.

Objectives: As model-based economic evaluations (MBEEs) are widely used to make decisions in the context of policy, it is imperative that they represent clinical practice. Here, we assess the relevance of MBEEs on dabigatran for the prevention of stroke in patients with atrial fibrillation (AF).

Methods: We performed a systematic review on the basis of a developed questionnaire, tailored to oral anticoagulation in patients with AF. Read More

View Article

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S026646231
Publisher Site
http://dx.doi.org/10.1017/S0266462318000211DOI Listing
January 2018
5 Reads

HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE.

Int J Technol Assess Health Care 2018 Jan 18;34(3):276-289. Epub 2018 Jun 18.

School of Engineering,University of Warwick; Health Technology Assessment Division,International Federation of Medical and Biological Engineering.

Objectives: Current health technology assessment (HTA) methods guidelines for medical devices may benefit from contributions by biomedical and clinical engineers. Our study aims to: (i) review and identify gaps in the current HTA guidelines on medical devices, (ii) propose recommendations to optimize the impact of HTA for medical devices, and (iii) reach a consensus among biomedical engineers on these recommendations.

Methods: A gray literature search of HTA agency Web sites for assessment methods guidelines on devices was conducted. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000314DOI Listing
January 2018
11 Reads

ENVIRONMENTAL IMPACT ASSESSMENT OF A HEALTH TECHNOLOGY: A SCOPING REVIEW.

Int J Technol Assess Health Care 2018 Jan 13;34(3):317-326. Epub 2018 Jun 13.

Osteba,Basque Office for Health Technology Assessment.

Introduction: The Health Technology Expert Review Panel is an advisory body to Canadian Agency for Drugs and Technologies in Health (CADTH) that develops recommendations on health technology assessments (HTAs) for nondrug health technologies using a deliberative framework. The framework spans several domains, including the environmental impact of the health technology(ies). Our research objective was to identify articles on frameworks, methods or case studies on the environmental impact assessment of health technologies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462318000351DOI Listing
January 2018

COMPARATIVE EFFECTIVENESS AND SAFETY BETWEEN AMPHOTERICIN B LIPID-FORMULATIONS: A SYSTEMATIC REVIEW.

Int J Technol Assess Health Care 2018 Jan 13;34(3):343-351. Epub 2018 Jun 13.

Health Technology Assessment Unit,Hospital de Clinicas de Porto Alegre.

Objectives: It is not yet established the advantages between amphotericin B lipid complex (ABLC) and liposomal (L-AmB) in patients with invasive fungal infections refractory to usual doses of conventional AmB (d-AmB), previous renal impairment, or unacceptable d-AmB renal toxicity. This systematic review aims to compare ABLC and L-AmB effectiveness and safety outcomes in these subgroups of patients.

Methods: The search was performed on Medline, Cochrane Library, EMBASE, and LILACS databases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S026646231800034XDOI Listing
January 2018